Only 50% of hepatic angiomyolipomas have substantial fat component
•
Arterial phase: Prominent enhancement of nonfatty portion of lesion
Central vessels within lesion if mass is large
•
Fatty component of tumor results in hyperintense (high signal) foci on T1WI and T2WI
•
MR, fat suppression ± opposed-phase GRE imaging
TOP DIFFERENTIAL DIAGNOSES
•
Hepatocellular carcinoma
•
Postoperative state, liver
•
Metastases
Teratoma or liposarcoma
PATHOLOGY
•
Associated with tuberous sclerosis in < 10% of cases
But some patients likely have forme fruste tuberous sclerosis
DIAGNOSTIC CHECKLIST
•
Small, fat density hepatic mass in patient with tuberous sclerosis is almost certainly benign
•
Angiomyolipoma that is primarily myeloid or angioid may be indistinguishable from other hepatic tumors, including hepatocellular carcinoma
TERMINOLOGY
Abbreviations
•
Hepatic angiomyolipoma (AML)
Synonyms
•
Benign hepatic hamartoma
Definitions
•
Benign mesenchymal tumor composed of variable amounts of smooth muscle (myoid), fat (lipoid), and proliferating blood vessel (angioid) components
IMAGING
General Features
•
Best diagnostic clue
Well-circumscribed, mostly fatty mass in liver
•
Location
Liver is 2nd most common site (kidney is 1st)
•
Size
Variable; 0.3-36 cm in diameter
•
Key concepts
Round or lobulated solitary mass or multiple lesions with variable shape
Only 50% of hepatic angiomyolipomas have substantial fat component
–
Those without much fat are difficult to distinguish from other hepatic tumors
CT Findings
•
NECT
Well-defined mass with heterogeneous attenuation values due to presence of fat and soft tissue densities
–
May be almost completely fat or soft tissue density mass
•
CECT
Arterial phase: Prominent enhancement of nonfatty portion of lesion
Portal phase: Lesion shows hypoattenuation throughout mass
•
CTA
Central vessels within lesion if mass is large
Get Clinical Tree app for offline access